Peritoneal dialysis is a high quality and cost-effective dialysis modality
In the past decade the greatest increases in peritoneal dialysis utilization have occurred in China, Thailand and the USA; peritoneal dialysis utilization has decreased in parts of Europe and in Oceania
Asia has experienced the largest absolute growth in patients on dialysis, and is characterized by the largest regional variation in peritoneal dialysis utilization
Reimbursement schemes and government policy are important determinants of peritoneal dialysis epidemiology
Peritoneal dialysis first policies (Hong Kong and Thailand), the peritoneal dialysis favoured policy (China) and the home dialysis first model (Australia and New Zealand) have resulted in increased utilization of peritoneal dialysis
Major challenges to increased utilization of peritoneal dialysis — particularly in developing countries — include prohibitive costs, lack of trained medical personnel, disparities in health-care provision and a lack of infrastructure
As the global burden of chronic kidney disease continues to increase, so does the need for a cost-effective renal replacement therapy. In many countries, patient outcomes with peritoneal dialysis are comparable to or better than those with haemodialysis, and peritoneal dialysis is also more cost-effective. These benefits have not, however, always led to increased utilization of peritoneal dialysis. Use of this therapy is increasing in some countries, including China, the USA and Thailand, but has proportionally decreased in parts of Europe and in Japan. The variable trends in peritoneal dialysis use reflect the multiple challenges in prescribing this therapy to patients. Key strategies for facilitating peritoneal dialysis utilization include implementation of policies and incentives that favour this modality, enabling the appropriate production and supply of peritoneal dialysis fluid at a low cost, and appropriate training for nephrologists to enable increased utilization of the therapy and to ensure that rates of technique failure continue to decline. Further growth in peritoneal dialysis use is required to enable this modality to become an integral part of renal replacement therapy programmes worldwide.
Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Popovich, R. P. et al. Continuous ambulatory peritoneal dialysis. Ann. Intern. Med. 88, 449–456 (1978).
Oreopoulos, D. G., Robson, M., Izatt, S., Clayton, S. & deVeber, G. A. A simple and safe technique for continuous ambulatory peritoneal dialysis (CAPD). Trans. Am. Soc. Artif. Intern. Organs 24, 484–489 (1978).
Li, P. K. & Chow, K. M. Peritoneal dialysis-first policy made successful: perspectives and actions. Am. J. Kidney Dis. 62, 993–1005 (2013). This article discusses the successful implementation of a peritoneal dialysis first policy in Hong Kong.
Dhanakijcharoen, P., Sirivongs, D., Aruyapitipan, S., Chuengsaman, P. & Lumpaopong, A. The “PD First” policy in Thailand: three-years experiences J. Med. Assoc. Thai 94 (Suppl. 4), S153–161 (2011).
Rivara, M. B. & Mehrotra, R. The changing landscape of home dialysis in the United States. Curr. Opin. Nephrol. Hypertens. 23, 586–591 (2014).
Fresenius Medical Care. Fresenius Medical Care 2015 Annual Report: ESRD patients in 2015: A global perspective (FMC 2015).
Liyanage, T. et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 385, 1975–1982 (2015). This systematic review used the best available data to calculate the number of patients receiving renal replacement therapy worldwide as well as the unmet need for this therapy with projections to 2030.
Blake, P. G. Peritoneal dialysis in Asia: an external perspective. Perit. Dial. Int. 22, 258–264 (2002).
National Institute of Health. US Renal Data System 2015 Annual Data Report. Epidemiology of Kidney Disease in the United States. Chapter 13: International comparisons. Am. J. Kidney Dis. 67 (Suppl. 1), S291–334 (2016).
Leung, C. B., Cheung, W. L. & Li, P. K. Renal registry in Hong Kong - the first 20 years. Kidney Int. Suppl. 5, 33–38 (2015).
Jain, A. K., Blake, P., Cordy, P. & Garg, A. X. Global Trends in Rates of Peritoneal Dialysis. J. Am. Soc. Nephrol. 23, 533–544 (2012).
Yu, X. & Yang, X. Peritoneal dialysis in China: meeting the challenge of chronic kidney failure. Am. J. Kidney Dis. 65, 147–151 (2015).
Ministry of Health, P. R. China. Chinese National Renal Data System [online] http://www.cnrds.net, (2016).
Lo, W. K. Peritoneal dialysis in the far East—an astonishing situation in 2008. Perit. Dial. Int. 29 (Suppl. 2), S227–229 (2009).
Van Bui, P. How peritoneal dialysis has developed in Vietnam. Perit. Dial. Int. 28 (Suppl. 3), S63–66 (2008).
Naramura, T. et al. Dialysis and quality of dialysate in southeast Asian developing countries. Nephron Extra 4, 64–69 (2014).
Jha, V. Current status of end-stage renal disease care in South Asia. Ethn Dis. 19, S1–27-32 (2009).
Navva, P. K., Venkata Sreepada, S. & Nayak, K. S. Present status of renal replacement therapy in Asian countries. Blood Purif. 40, 280–287 (2015).
Liu, F. X. et al. A global overview of the impact of peritoneal dialysis first or favored policies: an opinion. Perit. Dial. Int. 35, 406–420 (2015). A summary of the lessons learned from the success and failure of various peritoneal dialysis policies in different countries.
Choi, J. Y. et al. Survival advantage of peritoneal dialysis relative to hemodialysis in the early period of incident dialysis patients: a nationwide prospective propensity-matched study in Korea. PLoS ONE 8, e84257 (2013).
Li, P. K. & Szeto, C. C. Success of the peritoneal dialysis programme in Hong Kong. Nephrol. Dial Transplant 23, 1475–1478 (2008).
Kawaguchi, Y. National comparisons: optimal peritoneal dialysis outcomes among Japanese patients. Perit. Dial. Int. 19 (Suppl. 3), S9–16 (1999).
Ho, Y. W. et al. Hong Kong Renal Registry Report 2012. Hong Kong J. Nephrol. 15, 28–43 (2013).
Yu, X., Yang, X. & Huang, N. Management of a rapidly growing peritoneal dialysis population at the First Affiliated Hospital of Sun Yat-sen University. Perit Dial Int. 34 (Suppl. 2), S31–34 (2014).
Jose, M. D. et al. Peritoneal dialysis practice in Australia and New Zealand: A call to action. Nephrology 16, 19–29 (2011).
Yang, X., Mao, H. P., Guo, Q. Y. & Yu, X. Q. Successfully managing a rapidly growing peritoneal dialysis program in Southern China. Chin. Med. J. (Engl.) 124, 2696–2700 (2011).
Joshi, U. et al. Clinical outcomes in elderly patients on chronic peritoneal dialysis: a retrospective study from a single center in china. Perit. Dial. Int. 34, 299–307 (2014).
Yang, X. et al. Clinical outcome and risk factors for mortality in Chinese patients with diabetes on peritoneal dialysis: a 5-year clinical cohort study. Diabetes Res. Clin. Pract. 100, 354–361 (2013).
Li, P. K. et al. Increasing home-based dialysis therapies to tackle dialysis burden around the world: A position statement on dialysis economics from the 2nd Congress of the International Society for Hemodialysis. Nephrology 16, 53–56 (2011).
Li, P. K. & Chow, K. M. Peritoneal dialysis patient selection: characteristics for success. Adv. Chron. Kidney Dis. 16, 160–168 (2009).
Morad, Z. & Choong, H. L., Tungsanga, K. & Suhardjono. Funding renal replacement therapy in southeast Asia: building public-private partnerships in Singapore, Malaysia, Thailand, and Indonesia. Am. J. Kidney Dis. 65, 799–805 (2015).
Utas, C. The development of PD in Turkey. Perit. Dial. Int. 28, 217–219 (2008).
Wen, J. Report on the work of the government. wsj.com [online] http://online.wsj.com/public/resources/documents/2012NPC_GovtWorkReport_English.pdf, (2012).
Chen, Z. Good news for end stage renal disease patients. Chin. Med. J. (Engl.) 126, 4203 (2013).
Zhang, Z. & Zhao, K. The report of dialysis assessment and payment for end-stage renal disease in China. (National Health Development Research Center, 2011).
Ivarsen, P. & Povlsen, J. V. Can peritoneal dialysis be applied for unplanned initiation of chronic dialysis? Nephrol. Dial Transplant 29, 2201–2206 (2014).
Kumar, V. et al. Peritoneal dialysis: the great savior during disasters. Perit. Dial. Int. 33, 327–329 (2013).
Johnson, D. W. et al. Renal services disaster planning: Lessons learnt from the 2011 Queensland floods and North Queensland cyclone experiences. Nephrology 18, 41–46 (2013).
United Nations Population Division. World population prospects, the 2010 revision [online] http://www.un.org/en/development/desa/publications/world-population-prospects-the-2010-revision.html, (2011).
National Institue of Health. US Renal Data System 2014 Annual Data Report. Epidemiol. Kidney Dis. United States. Am. J. Kidney Dis. 66 (Suppl. 1), S1–306 (2015).
Li, P. K. et al. Good patient and technique survival in elderly patients on continuous ambulatory peritoneal dialysis. Perit. Dial. Int. 27 (Suppl. 2), S196–201 (2007).
Abraham, G. et al. Chronic peritoneal dialysis in South Asia - challenges and future. Perit. Dial. Int. 28, 13–19 (2008).
Xu, R. et al. Impact of individual and environmental socioeconomic status on peritoneal dialysis outcomes: a retrospective multicenter cohort study. PLoS ONE 7, e50766 (2012).
Johnson, D. W. et al. Biocompatible versus standard peritoneal dialysis fluid - the balANZ trial. J. Am. Soc. Nephrol. 23, 1097–1107 (2012).
The Australia and New Zealand Dialysis and Transplant Registry. The 38th Annual ANZDATA Report [online] http://www.anzdata.org.au. (2015).
Cho, Y. & Johnson, D. W. Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes. Am. J. Kidney Dis. 64, 278–289 (2014).
Johnson, D. W. et al. Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes. Kidney Int. 77, 904–912 (2010).
Lim, W. H. et al. Remote indigenous peritoneal dialysis patients have higher risk of peritonitis, technique failure, all-cause and peritonitis-related mortality. Nephrol. Dial. Transplant. 26, 3366–3372 (2011).
Cho, Y. et al. The effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: a multi-centre registry study. BMC Nephrol. 13, 41 (2012).
Lim, W. H., Johnson, D. W. & McDonald, S. P. Higher rate and earlier peritonitis in Aboriginal patients compared to non-Aboriginal patients with end-stage renal failure maintained on peritoneal dialysis in Australia: analysis of ANZDATA. Nephrology 10, 192–197 (2005).
Badve, S. V., Hawley, C. M. & Johnson, D. W. Adherence to guideline recommendations for infection prophylaxis in peritoneal dialysis patients. Nephrol. Dial Transplant. Plus 2, 508–508 (2009).
Ghali, J. R. et al. Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit. Dial. Int. 31, 651–662 (2011).
Morrish, A. T. et al. Establishing a clinical trials network in nephrology: experience of the Australasian Kidney Trials Network. Kidney Int. 85, 23–30 (2014).
Johnson, D., Brown, F., Lammi, H. & Walker, R. The CARI guidelines. Dialysis adequacy (PD) guidelines. Nephrology 10 (Suppl. 4), S81–107 (2005).
Walker, A. et al. KHA-CARI Guideline: peritonitis treatment and prophylaxis. Nephrology 19, 69–71 (2014).
Campbell, D. J. et al. Assessment of current practice and barriers to antimicrobial prophylaxis in peritoneal dialysis patients. Nephrol. Dial Transplant. 31, 619–627 (2016).
Toussaint, N. D. et al. Introduction of renal key performance indicators associated with increased uptake of peritoneal dialysis in a publicly funded health service. Perit. Dial. Int. http://dx.doi.org/10.3747/pdi.2016.00149 (2016).
Mudge, D. W. et al. Peritoneal dialysis practice in Australia and New Zealand: a call t sustain the action. Nephrology (Carlton) 21, 535–546 (2016).
ERA–EDTA Registry. ERA–EDTA Registry [online] https://www.era-edta-reg.org, (2016).
van de Luijtgaarden, M. W. et al. Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period. Nephrol. Dial Transplant. 31, 120–128 (2016).
Pippias, M. et al. The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry. Nephrol. Dial Transplant 31, 831–841 (2016).
Machowska, A. & Rutherford, P. Peritoneal dialysis use within the context of the population and healthcare systems of Europe - differences, trends and future challenges. Int. J. Artif. Orgns 39, 211–219 (2016).
Desmet, J. M. et al. Perceptive barriers to peritoneal dialysis implementation: an opinion poll among the French-speaking Belgian nephrologists. Clin. Kidney J. 6, 358–362 (2013).
Van Biesen, W., Veys, N., Lameire, N. & Vanholder, R. Why less success of the peritoneal dialysis programmes in Europe? Nephrol. Dial Transplant 23, 1478–1481 (2008).
Lameire, N. & Van Biesen, W. Epidemiology of peritoneal dialysis: a story of believers and nonbelievers. Nat. Rev. Nephrol. 6, 75–82 (2010).
Van Biesen, W., van der Veer, S. N., Murphey, M., Loblova, O. & Davies, S. Patients' perceptions of information and education for renal replacement therapy: an independent survey by the European Kidney Patients' Federation on information and support on renal replacement therapy. PLoS ONE 9, e103914 (2014).
Vanholder, R., Lameire, N., Annemans, L. & Van Biesen, W. Cost of renal replacement: how to help as many as possible while keeping expenses reasonable? Nephrol. Dial Transplant 31, 1251–1261 (2016).
Foster, T. L., Ferrantelli, E., van Wier-van der Schaaf, T. & Beelen, R. H. European Training and Research in Peritoneal Dialysis: scientific objectives, training, implementation and impact of the programme. J. Ren Care 40, 34–39 (2014).
Machowsk, A. et al. European Training and Research in Peritoneal Dialysis - a network to deliver scientific peritoneal dialysis training to a new generation of researchers. Adv. Perit. Dial. 31, 26–29 (2015).
Wang, V. et al. Geographic and temporal trends in peritoneal dialysis services in the United States between 1995 and 2003. Am. J. Kidney Dis. 55, 1079–1087 (2010).
Mehrotra, R. et al. Chronic peritoneal dialysis in the United States: declining utilization despite improving outcomes. J. Am. Soc. Nephrol. 18, 2781–2788 (2007).
Mehrotra, R. et al. Ownership patterns of dialysis units and peritoneal dialysis in the United States: utilization and outcomes. Am. J. Kidney Dis. 54, 289–298 (2009).
Sedor, J. R. et al. ASN End-Stage Renal Disease Task Force: perspective on prospective payments for renal dialysis facilities. J. Am. Soc. Nephrol. 21, 1235–1237 (2010).
Mehrotra, R., Chiu, Y. W., Kalantar-Zadeh, K., Bargman, J. & Vonesh, E. Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch. Intern. Med. 171, 110–118 (2011). This large US study shows no significant overall difference in patient outcomes with peritoneal dialysis and haemodialysis in cohorts that initiated renal replacement therapy in 1996–1998, 1999–2001 and 2002–2004.
Weinhandl, E. D. et al. Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J. Am. Soc. Nephrol. 21, 499–506 (2010).
Lacson, E. Jr et al. Effects of a nationwide predialysis educational program on modality choice, vascular access, and patient outcomes. Am. J. Kidney Dis. 58, 235–242 (2011).
Ghaffari, A. Urgent-start peritoneal dialysis: a quality improvement report. Am. J. Kidney Dis. 59, 400–408 (2012).
Mehrotra, R. Long-term outcomes in automated peritoneal dialysis: similar or better than in continuous ambulatory peritoneal dialysis? Perit. Dial. Int. 29 (Suppl. 2), S111–S114 (2009).
Mehrotra, R., Chiu, Y. W., Kalantar-Zadeh, K. & Vonesh, E. The outcomes of continuous ambulatory and automated peritoneal dialysis are similar. Kidney Int. 76, 97–107 (2009).
Jensen, V. & Throckmorton, D. C. Shortage of peritoneal dialysis solution and the Food and Drug Administration's Response. Clin. J. Am. Soc. Nephrol. 10, 1484–1486 (2015).
Canadian Organ Replacement Register. Canadian Organ Replacement Register Annual Report: Treatment of End-Stage Organ Failure in Canada, 2004 to 2013 [online] https://secure.cihi.ca/free_products/2015_CORR_AnnualReport_ENweb.pdf, (2015).
Jindal, K. Revitalizing peritoneal dialysis: the Ontario approach. Perit Int. Dial 27, 526–528 (2007).
Perl, J. et al. Changes in patient and technique survival over time among incident peritoneal dialysis patients in Canada. Clin. J. Am. Soc. Nephrol. 7, 1145–1154 (2012).
Wong, L. P. et al. Urgent peritoneal dialysis starts for ESRD: initial multicenter experience in the United States. Am. J. Kidney Dis. 68, 500–502 (2016).
Afolalau, B. et al. Technique failure and center size in a large cohort of peritoneal dialysis patients in a defined geographic area. Perit. Dial. Int. 29, 292–296 (2009).
Plantinga, C. L. et al. Association of peritoneal dialysis clinic size with clinical outcomes. Perit. Dial. Int. 29, 285–291 (2009).
Gonzalez-Bedat, M. et al. Burden of disease: prevalence and incidence of ESRD in Latin America. Clin. Nephrol. 83, 3–6 (2015).
Pecoits-Filho, R. et al. Policies and health care financing issues for dialysis in Latin America: extracts from the roundtable discussion on the economics of dialysis and chronic kidney disease. Perit. Dial. Int. 29 (Suppl. 2), S222–226 (2009).
Thomas, B. et al. Maintenance dialysis throughout the world in years 1990 and 2010. J. Am. Soc. Nephrol. 26, 2621–2633 (2015).
Rosa-Diez, G. et al. Renal replacement therapy in Latin American end-stage renal disease. Clin. Kidney J. 7, 431–436 (2014). The Latin American Dialysis and Renal Transplant Registry (RLADTR) provides the best landscape of renal replacement therapy in this region, similar to USRDS in the USA.
Rosa-Diez, G. et al. Burden of end-stage renal disease (ESRD) in Latin America. Clin. Nephrol. 86 (Suppl. 1), 29–33 (2016). This study reports registry data that highlights the wide range of access to nephrologists across Latin America, ranging from 1.8 pmp in Honduras to 45.2 pmp in Cuba.
Cusumano, A. M., Rosa-Diez, G. & Gonzalez-Bedat, M. C. Latin America Dialysis and Transplant Registry: experiencce and contributions to end-stage renal disease epidemiology. World J. Nephrol. 5, 389–397 (2016).
Pecoits-Filho, R. et al. Overview of peritoneal dialysis in Latin America. Perit. Dial. Int. 27, 316–321 (2007).
de Moraes, T. P. et al. Characterization of the BRAZPD II cohort and description of trends in peritoneal dialysis outcome across time periods. Perit. Dial. Int. 34, 714–723 (2014). This large cohort study shows an improvement in patient survival on peritoneal dialysis in Brazil despite a high percentage of patients with diabetes.
Naidoo, S. et al. Peritoneal dialysis in South Africa - a single centre experience. Indian J. Perit. Dial. 13, 18–21 (2008).
Abu-Aisha, H. & Elamin, S. Peritoneal dialysis in Africa. Perit. Dial. Int. 30, 23–28 (2010).
Swanepoel, C. R., Wearne, N. & Okpechi, I. G. Nephrology in Africa—not yet uhuru. Nat. Rev. Nephrol. 9, 610–622 (2013). This article reviews the currently limited epidemiological data on dialysis utilization in Africa, including dialysis for acute kidney injury and chronic kidney disease.
Bamgboye, E. L. The challenges of ESRD care in developing economies: sub-Saharan African opportunities for signficant improvement. Clin. Nephrol. 86 (Suppl. 1), 18–22 (2016).
Elamin, S., Obeid, W. & Abu-Aisha, H. Renal replacement therapy in Sudan, 2009. Arab J. Nephrol. Transplant. 3, 31–36 (2010).
El Matri, A., Elhassanb, E. A. M. & Abu-Aisha, H. Renal replacement therapy resources in Africa. Arab J. Nephrol. Transplant. 1, 9–14 (2008).
Karopadi, A. N., Mason, G., Rettore, E. & Ronco, C. The role of economies of scale in the cost of dialysis across the world: a macroeconomic perspective. Nephrol. Dial Transplant 29, 885–892 (2014).
Lo, W. K. Role of the International Society for Peritoneal Dialsysis (ISPD) in the future of peritoneal dialysis. Contrib. Nephrol. 163, 311–319 (2009).
P.K.-T.L. is the Immediate Past President of the International Society for Peritoneal Dialysis (ISPD). D.W.J. is the President Elect of ISPD and has received consultancy fees, research grants, speaker's honoraria and travel sponsorships from Baxter Healthcare and Fresenius Medical Care. K.J.J. has received speaker's honoraria from Fresenius Medical Care. R.M. is the Treasurer of ISPD. S.N. chairs the Award Committee of ISPD. R.P.F. has received research grants from Baxter Healthcare and Fresenius Medical Care. X.Q.Y. chairs the Membership Committee of ISPD and has received consultancy fees, research grants, speaker's honoraria and travel sponsorships from Baxter Healthcare and speaker's honoraria and travel sponsorships from Fresenius Medical Care. K.M.C., M.W.M.V.L. and N.L. declare no competing interests.
Epidemiology of peritoneal dialysis in Australia and New Zealand 2003–2013 (PDF 115 kb)
Trends in the incidence and prevalence of renal replacement therapy modalities at day 91 during 2005–2012 in Europe* (PDF 113 kb)
5-year survival of patients starting dialysis in Europe between 2005 and 2007 (PDF 121 kb)
The prevalence of patients with end-stage renal disease undergoing PD in the USA from 2003 through 2012. (PDF 93 kb)
- Continuous ambulatory peritoneal dialysis
A continuous renal replacement therapy process in which solutes and fluid are exchanged between blood in the peritoneal capillaries and dialysis solution in the peritoneal cavity by crossing the peritoneal membrane. Patients usually perform 3–4 manual exchanges per day.
- Technique survival
The likelihood of remaining on peritoneal dialysis. Technique failure is generally defined as any peritoneal-dialysis-related complication that leads to permanent cessation of the therapy (including peritoneal dialysis-related death), and less commonly a switch to haemodialysis for a period of at least 1 month.
- Home dialysis first model
A model of care in which home dialysis is the default option for patients who require renal replacement therapy. Rather than assessing a patient's suitability for home dialysis, patients are assumed to be appropriate for this modality before the application of any exclusion criteria.
- Automated peritoneal dialysis
A peritoneal dialysis modality in which an automated cycler is programmed to perform multiple exchanges overnight. To enable peritoneal dialysis in the daytime, the cycler can be programed to perform a final fill before the patient disconnects in the morning.
About this article
Cite this article
Li, PT., Chow, K., Van de Luijtgaarden, M. et al. Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol 13, 90–103 (2017). https://doi.org/10.1038/nrneph.2016.181
Change in appendicular lean mass in patients established on peritoneal dialysis as measured by dual x-ray absorptiometry (DXA) scanning
European Journal of Clinical Nutrition (2021)
From “feeling” to “seeing”: modification of the percutaneous peritoneal dialysis catheter insertion with an optical puncture system
International Urology and Nephrology (2021)
Aberrant serum parathyroid hormone, calcium, and phosphorus as risk factors for peritonitis in peritoneal dialysis patients
Scientific Reports (2021)
The effects of Fushen Granule on the composition and function of the gut microbiota during Peritoneal Dialysis–Related Peritonitis
Cost-effectiveness analysis of renal replacement therapy strategies in Guangzhou city, southern China
BMJ Open (2021)